[PDF][PDF] Jaruwan Ngamkam1, Somratai Vadcharavivad1Ε, Nutthada Areepium1, Titinun Auamnoy2, Kullaya Takkavatakarn3, Pisut Katavetin3, Khajohn …
K Praditpornsilpa, S Eiam‑Ong… - Scientific Reports, 2021 - academia.edu
Results Characteristics of the study population. A total of 135 Thai HD patients with SHPT
participated in this study (Fig. 1). The characteristics of the participants are summarized in …
participated in this study (Fig. 1). The characteristics of the participants are summarized in …
[HTML][HTML] Rapid decrease of intact parathyroid hormone could be a predictor of better response to cinacalcet in hemodialysis patients
Purpose Cinacalcet is effective for treating refractory secondary hyperparathyroidism
(SHPT), but little is known about the response rates and clinical factors influencing the …
(SHPT), but little is known about the response rates and clinical factors influencing the …
WCN23-1095 FACTORS AFFECTING UNSUCCESSFUL RESPONSES OF CINACALCET IN DIALYSIS PATIENTS
C Chatnarongchai, S Anumas… - Kidney International …, 2023 - kireports.org
Methods A retrospective cohort study was conducted at Thammasat University Hospital
between January 1 st, 2015 and June 30 th, 2021. Primary outcome was unsuccessful …
between January 1 st, 2015 and June 30 th, 2021. Primary outcome was unsuccessful …
P0890 EFFICACY AND SAFETY OF CINACALCET IN CHINESE MAINTENANCE HEMODIALYSIS PATIENTS WITH DIFFERENT STAGES OF SECONDARY …
A Jiang, P Fu, G Xiao, J Ye, Z Liu… - Nephrology Dialysis …, 2020 - academic.oup.com
Abstract Background and Aims Chronic kidney disease (CKD) is a major public health issue
worldwide including in China. One of the most common complication in advanced Chronic …
worldwide including in China. One of the most common complication in advanced Chronic …
Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favourable control of the serum phosphorus and calcium levels in Japanese dialysis …
M Fukagawa, S Yumita, T Akizawa… - Nephrology Dialysis …, 2008 - academic.oup.com
Abstract Background. Cinacalcet hydrochloride (KRN1493) acts on the parathyroid calcium
receptors to suppress parathyroid hormone (PTH) secretion, and is already in wide use in …
receptors to suppress parathyroid hormone (PTH) secretion, and is already in wide use in …
[PDF][PDF] " Real-World" use of cinacalcet for managing SHPT in different European countries: analysis of data from the ECHO observational study
M Vervloet, V Bencova, F Malberti, N Ashman… - Clinical …, 2010 - researchgate.net
Aims: The pan-European ECHO observational study evaluated cinacalcet in adult dialysis
patients with secondary hyperparathyroidism (SHPT) in “real-world” clinical practice. A sub …
patients with secondary hyperparathyroidism (SHPT) in “real-world” clinical practice. A sub …
Impact of cinacalcet hydrochloride on the achievement of the Japanese Society for Dialysis Therapy (JSDT) guideline targets: a post‐hoc analysis of the KRN1493 …
H Komaba, M Fukagawa - Therapeutic Apheresis and Dialysis, 2008 - Wiley Online Library
Abstract The Japanese Society for Dialysis Therapy (JSDT) released the Guidelines for the
Management of Secondary Hyperparathyroidism in Chronic Dialysis Patients (JSDT …
Management of Secondary Hyperparathyroidism in Chronic Dialysis Patients (JSDT …
A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis
M Chonchol, F Locatelli, HE Abboud… - American Journal of …, 2009 - Elsevier
BACKGROUND: Secondary hyperparathyroidism is observed in patients with early chronic
kidney disease (CKD). This study investigated the safety and efficacy of cinacalcet for …
kidney disease (CKD). This study investigated the safety and efficacy of cinacalcet for …
Cinacalcet for managing secondary hyperparathyroidism in dialysis patients in clinical practice in Belgium: a 16-month observational study (ECHO-B)
F Debelle, G Meeus, M Dratwa, B Maes… - Acta Clinica …, 2013 - Taylor & Francis
In Belgium, the calcimimetic cinacalcet is initially reimbursed for≤ 4 months in dialysis
patients with secondary hyperparathyroidism (SHPT) and intact parathyroid hormone …
patients with secondary hyperparathyroidism (SHPT) and intact parathyroid hormone …
Evaluating real-world use of cinacalcet and biochemical response to therapy in US hemodialysis patients
RD Kilpatrick, BB Newsome, D Zaun, J Liu… - American Journal of …, 2013 - karger.com
Abstract Background/Aims: Data describing real-world use and effectiveness of cinacalcet
are limited. We aimed to characterize predictors of treatment and changes in secondary …
are limited. We aimed to characterize predictors of treatment and changes in secondary …